Furthermore, to explore the potential isoform-dependent modulation of PP1 activity by the CAVPENET bioportide, the viability of the PCa cells after knockdown of PP1α, PP1β and PP1γ alone or in combination with CAVPENET was assessed. The gene discussed is PPP1CA; the disease is posterior cortical atrophy.